Ascletis Pharmaceuticals Co., Ltd.

This study followed patients with moderate to severe acne to check the long-term safety of an oral medication called ASC40 (Denifanstat). The 240 participants, who had already completed a previous 12-week study, took the tablet once daily for up to 40 weeks. The main goal was to …

This early-stage trial tested a new oral medication called ASC61 in 18 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find the safest dose, see how the body processes the drug, and look for early signs that it might he…